Microbot Medical Inc has advanced its Liberty Robotic System to the next phase of evaluation, marking a pivotal step in the development of remote telesurgery capabilities. This progression highlights Microbot's commitment to revolutionising surgical practices by leveraging cutting-edge robotic technology, according to GlobalData, a leading data and analytics company.

GlobalData projects that the global market for robotic surgical systems and their accessories will reach $10 billion by the end of 2024 with a substantial increase expected to hit $15.8 billion by 2030. This growth reflects the rising demand for these technologies, fueled by an increasing need for precise, minimally invasive surgical solutions for an ageing population, a stronger focus on value-based healthcare to enhance surgical outcomes, and ongoing technological advancements anticipated to produce more efficient and less invasive robotic surgical platforms.

Graysen Vigneux, medical analyst at GlobalData, comments: “Microbot's advancement of the Liberty Robotic System into its next evaluation phase is a significant milestone for the field of telesurgery. This system has the potential to redefine the landscape of minimally invasive surgery by providing surgeons with enhanced control and accuracy, irrespective of their physical location.”

Robot surgery meets need for high precision

The Liberty Robotic System is designed to perform intricate surgical procedures with minimal human intervention, using advanced robotics to facilitate remote operations. The system's capabilities are expected to address critical challenges in the healthcare sector, including the shortage of skilled surgeons in remote areas and the need for high precision in complex surgeries.

Vigneux concludes: “The development of the Liberty Robotic System underscores Microbot's innovative approach to addressing some of the most pressing challenges in modern healthcare. By advancing remote telesurgery, Microbot is not only enhancing surgical outcomes but also paving the way for more accessible healthcare services worldwide.”

As Microbot continues to refine the Liberty Robotic System, the company remains focused on ensuring that the technology meets the highest standards of safety and efficacy. This commitment is expected to drive further innovation in the field of robotic surgery and contribute to the overall growth of the global surgical robotics market.

"Microbot Medical advances Liberty Robotic System telesurgery innovation" was originally created and published by Medical Device Network, a GlobalData owned brand.